Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
123.1 USD | +0.99% | -2.17% | +23.54% |
May. 07 | UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating | MT |
May. 06 | News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.54% | 46.71B | |
+48.83% | 41.8B | |
-1.04% | 41.52B | |
-3.42% | 29.55B | |
+10.82% | 25.78B | |
-21.12% | 19.26B | |
-0.25% | 12.14B | |
+0.11% | 12.08B | |
+26.13% | 11.98B | |
+18.78% | 11.58B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna Reportedly Pausing Plan to Build Kenya Vaccine Production Plant